Quantcast
Home > Quotes > AMDA
AMDA

Amedica Corporation Common Stock (AMDA) Quote & Summary Data

$0.51
*  
unch
unch
Get AMDA Alerts
*Delayed - data as of Jul. 18, 2018  -  Find a broker to begin trading AMDA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    AMDA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.5001 / $ 0.52
1 Year Target
4.35
Today's High / Low
$ 0.54 / $ 0.501
Share Volume
177,691
50 Day Avg. Daily Volume
1,286,757
Previous Close
$ 0.51
52 Week High / Low
$ 6.9351 / $ 0.50
Market Cap
3,684,362
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-2.88

Intraday Chart

Shares Traded

Share Volume:
177,691
50 Day Avg. Daily Volume:
1,286,757

Trading Range

The current last sale of $0.51 is 2.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.54 $ 6.9351
 Low: $ 0.501 $ 0.50

Company Description (as filed with the SEC)

We are a materials company focused on developing, manufacturing and selling silicon nitride ceramics that are used in medical implants and in a variety of industrial devices. At present, we commercialize silicon nitride in the spine implant market. We believe that our versatile silicon nitride manufacturing expertise positions us favorably to introduce new and innovative devices in the medical and non-medical fields. We also believe that we are the first and only company to commercialize silicon nitride medical implants. We have received 510(k) regulatory clearance in the United States, a CE mark in Europe, ANVISA approval in Brazil, and ARTG and Prostheses approvals in Australia for a number of our devices that are designed for spinal fusion surgery. To date, more than 33,000 of our silicon nitride devices have been implanted into patients, with a 10-year successful track record.  ... More ...  

Risk Grade

Where does AMDA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.54
Open Date:
Jul. 18, 2018
Close Price:
$ 0.51
Close Date:
Jul. 18, 2018

Consensus Recommendation

Analyst Info